Aurobindo Pharma Shares Climb 19% after USFDA Issues EIR for Unit IV

EIR is basically a factual report on all the activities conducted by FDA investigators during the time spent at the manufacturing establishment.

from Top Business News- News18.com https://ift.tt/39Jfhxt